Craft

U.S. NeuroSurgical

Stock Price

$0.7

2024-10-29

Market Capitalization

$9.4 M

2024-10-29

Revenue

$1 M

FY, 2025

U.S. NeuroSurgical Summary

Company Summary

Overview
U.S. NeuroSurgical is a medical services company that partners with hospitals and physicians to own and operate facilities utilizing state-of-the-art and innovative technologies in medical treatment and/or diagnosis. The Company takes the financial risk for the facility and participates with local partners in promoting the success of the project. U.S. NeuroSurgical is focusing on establishing cancer centers using intensity-modulated radiation therapy (IMRT) and/or image-guided radiation therapy (IGRT) in Florida and other parts of the United States. Its gamma knife is a stereotactic radiosurgical device used to treat brain tumors and other malformations of the brain without invasive surgery.
Type
Public
Status
Active
Founded
1993
HQ
Rockville, MD, US | view all locations
Website
http://www.usneuro.com/
Cybersecurity rating
Sectors

LocationsView all

1 location detected

  • Rockville, MD HQ

    United States

    2400 Research Blvd #325Rockville

U.S. NeuroSurgical Financials

Summary Financials

Revenue (FY, 2025)
$1.0M
Gross profit (FY, 2025)
$118.0K
Net income (FY, 2025)
($7.8M)
Cash (FY, 2025)
$3.8M
EBIT (FY, 2025)
($3.8M)
Enterprise value
$5.8M

Footer menu